Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
8.77
-0.03 (-0.34%)
Aug 26, 2026, 2:49 PM EDT - Market open

Phathom Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-99.07-221.25-334.33-201.59-197.72-143.88
Depreciation & Amortization
0.510.630.80.580.620.52
Other Amortization
3.343.012.191.882.113.6
Stock-Based Compensation
27.1528.7224.0545.0324.1316.81
Other Operating Activities
24.7134.4855.8230.1818.891.81
Change in Accounts Receivable
-46.17-39.33-37.16-1.64--
Change in Inventory
-0.89-11.78-6.14-9.44--
Change in Accounts Payable
48.9634.134.946.418.68-9.79
Change in Other Net Operating Assets
4.774.63-6.93-8.98-3.24-17.52
Operating Cash Flow
-36.69-166.78-266.77-137.58-146.53-148.46
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.22-0.23-0.14-1.63-1.04-0.33
Investing Cash Flow
-0.22-0.23-0.14-1.63-1.04-0.33

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--59.4211.9995.4596.89
Total Debt Issued
173.25-59.4211.9995.4596.89
Long-Term Debt Repaid
------54.13
Net Debt Issued (Repaid)
-55.8-59.4211.9995.4542.76
Issuance of Common Stock
127.671.64123.37155.5924.61.94
Repurchase of Common Stock
-2.05-1.93----
Financing Cash Flow
69.82-0.29182.77367.58120.0444.71

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
32.91-167.29-84.13228.37-27.53-104.08

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-36.91-167-266.91-139.21-147.57-148.79
Free Cash Flow Growth
------
Free Cash Flow Margin
-15.40%-95.37%-483.07%-20412.61%--
Free Cash Flow Per Share
-0.47-2.29-4.22-2.71-3.77-4.02
Levered Free Cash Flow
-32.63-107.86-203.85-90.45-93.78-96.73
Unlevered Free Cash Flow
3.67-68.3-161.04-66.1-78.83-96.08

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
20.1221.3717.2911.137.034.07
Change in Working Capital
6.67-12.38-15.3-13.645.44-27.32
SEC Filings: 10-K · 10-Q